Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WPCB
3726
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
| $200K | ﹤0.01% |
19,781
| – | – |
|
3727
First Watch Restaurant Group
FWRG
$788M
| $199K | ﹤0.01% |
14,726
+322
| +2% | +$4.9K |
|
3728
Krispy Kreme
DNUT
$543M
| $199K | ﹤0.01% |
19,287
+16,242
| +533% | +$221K |
|
3729
LCNB Corp
LCNB
$284M
| $199K | ﹤0.01% |
11,046
| – | – |
|
|
GRCL
3730
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $198K | ﹤0.01% |
86,109
+47,379
| +122% | +$145K |
|
3731
Columbia Financial
CLBK
$1.12B
| $198K | ﹤0.01% |
9,143
+6,340
| +226% | +$136K |
|
3732
HCI Group
HCI
$2.28B
| $198K | ﹤0.01% |
4,990
-142
| -3% | -$5.23K |
|
3733
Axogen
AXGN
$2.47B
| $197K | ﹤0.01% |
19,766
+9,167
| +86% | +$102K |
|
3734
Radiant Logistics
RLGT
$387M
| $197K | ﹤0.01% |
38,613
+8,337
| +28% | +$46.7K |
|
3735
Unity Bancorp
UNTY
$600M
| $196K | ﹤0.01% |
7,175
+1,591
| +28% | +$43.7K |
|
3736
CNB Financial Corp
CCNE
$1.05B
| $195K | ﹤0.01% |
8,201
+6,919
| +540% | +$171K |
|
|
GOOD
3737
Gladstone Commercial Corp
GOOD
$600M
| $195K | ﹤0.01% |
10,519
+8,858
| +533% | +$158K |
|
3738
AdvisorShares Pure US Cannabis ETF
MSOS
$850M
| $194K | ﹤0.01% |
27,807
+2,300
| +9% | +$23.7K |
|
3739
PUT
Sprouts Farmers Market
SFM
$8.36B
| $194K | ﹤0.01% |
+6,000
| New | +$187K |
|
3740
ARKO Corp
ARKO
$889M
| $194K | ﹤0.01% |
22,401
+18,864
| +533% | +$175K |
|
3741
BioVie
BIVI
$11.8M
| $193K | ﹤0.01% |
+249
| New | +$135K |
|
3742
Bank First Corp
BFC
$1.72B
| $193K | ﹤0.01% |
2,075
+1,804
| +666% | +$160K |
|
3743
BrightView Holdings
BV
$1.24B
| $193K | ﹤0.01% |
27,939
+15,459
| +124% | +$119K |
|
3744
Franklin Covey
FC
$247M
| $192K | ﹤0.01% |
4,112
+3,090
| +302% | +$151K |
|
3745
CALL
CSX Corp
CSX
$93.1B
| $192K | ﹤0.01% |
+6,200
| New | +$186K |
|
3746
Safe Bulkers
SB
$797M
| $191K | ﹤0.01% |
65,609
+16,121
| +33% | +$44.6K |
|
3747
Compass
COMP
$8.73B
| $191K | ﹤0.01% |
81,934
+70,354
| +608% | +$185K |
|
3748
Universal Electronics
UEIC
$58.4M
| $191K | ﹤0.01% |
9,164
+2,282
| +33% | +$47.3K |
|
3749
PUT
Tower Semiconductor
TSEM
$25.6B
| $190K | ﹤0.01% |
+4,400
| New | +$191K |
|
3750
Bank of Marin Bancorp
BMRC
$476M
| $190K | ﹤0.01% |
5,773
+4,198
| +267% | +$141K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.